Literature DB >> 10480521

ACE gene polymorphism and proliferative retinopathy in type 1 diabetes: results of a case-control study.

D Rabensteiner1, H Abrahamian, K Irsigler, K M Hermann, H P Kiener, G Mayer, A Kaider, R Prager.   

Abstract

OBJECTIVE: To evaluate the relationship between the ACE insertion/deletion polymorphism and proliferative diabetic retinopathy in patients with type 1 diabetes of long duration. Based on epidemiological and pathophysiological findings, risk factors apart from glycemic control and duration of disease are likely to be involved in the development of proliferative retinopathy. RESEARCH DESIGN AND METHODS: In this case-control study, we compared 81 patients with longstanding (> or =20 years) type 1 diabetes who had nonproliferative (mild or moderate background) retinopathy with 95 patients with diabetes of similar duration and HbA1c who had proliferative retinopathy. To avoid the confounding effect of nephropathy, patients with overt nephropathy were excluded, and microalbuminuria was introduced into the multiple logistical regression model. The polymorphic region in intron 16 of the ACE gene (17q23) was analyzed using the polymerase chain reaction.
RESULTS: The ACE genotype distribution in patients with proliferative retinopathy (DD 39.4%, ID 48.9%, II 11.7%) was significantly different (P < 0.001) from that of patients with nonproliferative retinopathy (DD 17.3%, ID 54.3%, II 28.4%). In a multiple logistical regression analysis, the adjusted relative risk for proliferative retinopathy in a patient with a DD genotype compared with a patient with an II genotype was 6.6 (95% CI 2.2-19.5), P = 0.0026. In addition to genotype, systolic blood pressure (odds ratio 1.027 [95% CI 1.0-1.1], P = 0.0093) but not microalbuminuria (< or =20 vs. > or =20 microg/min) reached statistical significance in the multiple regression model. Because subjects were matched regarding diabetes duration and HbA1c, we did not interpret the respective parameter estimates.
CONCLUSIONS: These data provide evidence that deletion in the ACE gene is associated with the prevalence of proliferative retinopathy in type 1 diabetes and suggest that the DD genotype confers susceptibility to proliferative retinopathy independent of diabetic nephropathy

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10480521     DOI: 10.2337/diacare.22.9.1530

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  6 in total

1.  Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice.

Authors:  Masao Kakoki; Kelli A Sullivan; Carey Backus; John M Hayes; Sang Su Oh; Kunjie Hua; Adil M H Gasim; Hirofumi Tomita; Ruriko Grant; Sarah B Nossov; Hyung-Suk Kim; J Charles Jennette; Eva L Feldman; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

Review 2.  The kallikrein-kinin system in diabetic nephropathy.

Authors:  Hirofumi Tomita; Ryan B Sanford; Oliver Smithies; Masao Kakoki
Journal:  Kidney Int       Date:  2012-02-08       Impact factor: 10.612

3.  Association between the ACE insertion/deletion polymorphism and pterygium in Sardinian patients: a population based case-control study.

Authors:  Paolo Demurtas; Germano Orrù; Pierpaolo Coni; Luigi Minerba; Michela Corrias; Paola Sirigu; Ignazio Zucca; Elena Demurtas; Cristina Maxia; Franca Piras; Daniela Murtas; Simone Lai; Maria Teresa Perra
Journal:  BMJ Open       Date:  2014-10-23       Impact factor: 2.692

4.  Association between the Angiotensin-Converting Enzyme (ACE) Genetic Polymorphism and Diabetic Retinopathy-A Meta-Analysis Comprising 10,168 Subjects.

Authors:  Shasha Luo; Chao Shi; Furu Wang; Zhifeng Wu
Journal:  Int J Environ Res Public Health       Date:  2016-11-15       Impact factor: 3.390

5.  Lack of relationship between Alu repetitive elements in angiotensin converting enzyme and the severity of diabetic retinopathy.

Authors:  Abu-Hassan Diala Walid; Muawyah D Al-Bdour; Mohammed El-Khateeb
Journal:  J Med Biochem       Date:  2021-06-05       Impact factor: 3.402

Review 6.  The Potential Role of Genetic Markers in Talent Identification and Athlete Assessment in Elite Sport.

Authors:  Ysabel Jacob; Tania Spiteri; Nicolas H Hart; Ryan S Anderton
Journal:  Sports (Basel)       Date:  2018-08-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.